Articles Coming Soon!
In the mean time, visit us at izocorp.com
Articles Coming Soon!
In the mean time, visit us at izocorp.com
What is Breast CT?
No Compression, No Compromise.
Breast CT is a breakthrough in breast imaging!
Offering true 3D, high-resolution scans without painful compression. Breast CT technology is designed to revolutionize the global breast imaging industry, especially for the 50%+ of women with dense breast tissue, where other imaging technologies have fallen short.
Video
See IzoView in action
High resolution true 3D imaging in seconds, without breast compression or technician breast handling.
How well does it work?
Hear from the Radiologist who ran the clinical research trials on breast CT technology.
Frequently Asked Questions
IzoView is not yet commercially available, nor approved or cleared for sale. IzoView is ready to go through an exciting clinical study for FDA approval in the United States and CE Marking in Europe.
Izotropic Corporation is a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnosis, and treatment of breast cancers
We are the only publicly traded company in the world dedicated to commercializing advanced Breast CT technology. Our mission is to transform the patient experience and improve outcomes through innovation, precision, and compassion.
Yes! Izotropic Corporation is a publicly traded company that trades on the OTC: IZOZF in the U.S., CSE: IZO in Canada, and FSE: 1R3 in Germany.
Subscribe
One of our representatives will contact you.
Disclaimer
This website including any links, may contain statements that are "Forward-Looking Statements," which are based upon the current estimates, assumptions, projections, and expectations of the Company's management, business, and its knowledge of the relevant market and economic environment in which it operates. The Company has tried, where possible, to identify such information and statements by using words such as "anticipate," "believe," "envision," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," "contemplate" and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words.
These statements are not guarantees of performance and involve risks, including those related to capital requirements and uncertainties that are difficult to control or predict, and as such, they may cause future results of the Company's activity to differ significantly from the content and implications of such statements. Forward-Looking Statements are pertinent only as of the date on which they are made, and the Company undertakes no obligation to update or revise any Forward-Looking Statements to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. Neither the Company nor its shareholders, officers, and consultants shall be liable for any action and the results of any action taken by any person based on the information contained herein, including, without limitation, the purchase or sale of Company securities. Nothing in this document should be deemed to be medical or other advice of any kind. All images are for illustrative purposes only. IzoView has not yet been approved or cleared for sale.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.